These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1408 related articles for article (PubMed ID: 3361530)

  • 1. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 2. [Classification of progressive systemic scleroderma].
    Holzmann H; Sollberg S; Altmeyer P
    Hautarzt; 1987 May; 38(5):253-7. PubMed ID: 3497136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [News about scleroderma: survey of present state of research problems (author's transl)].
    Stáva Z; Kobíková M; Kolár J; Drugová B
    Cas Lek Cesk; 1974; 113(26):787-92. PubMed ID: 4844781
    [No Abstract]   [Full Text] [Related]  

  • 4. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
    Birnbaum NS; Rodnan GP; Rabin BS; Bassion S
    J Rheumatol; 1977; 4(4):425-8. PubMed ID: 604479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for the classification of early systemic sclerosis.
    LeRoy EC; Medsger TA
    J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?
    Cutolo M; Sulli A; Smith V
    Expert Rev Clin Immunol; 2011 Jul; 7(4):395-7. PubMed ID: 21790279
    [No Abstract]   [Full Text] [Related]  

  • 7. [Scleroderma--a vascular disease].
    Keplan D
    Ter Arkh; 1978; 50(9):102-4. PubMed ID: 705638
    [No Abstract]   [Full Text] [Related]  

  • 8. The spectrum of scleroderma.
    LeRoy EC; Lomeo R
    Hosp Pract (Off Ed); 1989 Oct; 24(10A):33-42 contd. PubMed ID: 2509491
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary criteria for the classification of systemic sclerosis (scleroderma).
    Bull Rheum Dis; 1981; 31(1):1-6. PubMed ID: 7459513
    [No Abstract]   [Full Text] [Related]  

  • 10. [Scleroderma].
    Hébert J; Mathon G; Mathieu JP
    Union Med Can; 1981 Mar; 110(3):209-20. PubMed ID: 7245418
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical heterogeneity of the scleroderma group of diseases].
    Guseva NG
    Ter Arkh; 1992; 64(8):109-12. PubMed ID: 1440384
    [No Abstract]   [Full Text] [Related]  

  • 12. Classification and pathogenesis of scleroderma.
    Winkelmann RK
    Mayo Clin Proc; 1971 Feb; 46(2):83-91. PubMed ID: 4925984
    [No Abstract]   [Full Text] [Related]  

  • 13. The phenomenon, syndrome and disease of Maurice Raynaud.
    Belch JJ
    Br J Rheumatol; 1990 Jun; 29(3):162-5. PubMed ID: 2357495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research of an association between HL-A antigens and systemic scleroderma].
    Crouzet J; Marbach MC; Camus JP; Godeau P; Herreman G; Richier D; Hors J; Dausset J
    Nouv Presse Med; 1975 Oct; 4(35):2489-92. PubMed ID: 1196871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis (scleroderma) and multiple sclerosis.
    Trostle DC; Helfrich D; Medsger TA
    Arthritis Rheum; 1986 Jan; 29(1):124-7. PubMed ID: 3947408
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of blood vessels in the pathogenesis of diffuse scleroderma].
    Kamiński A
    Przegl Dermatol; 1974; 61(5):639-47. PubMed ID: 4278576
    [No Abstract]   [Full Text] [Related]  

  • 17. Nodular scleroderma: a report of 2 cases.
    Wriston CC; Rubin AI; Elenitsas R; Crawford GH
    Am J Dermatopathol; 2008 Aug; 30(4):385-8. PubMed ID: 18645312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification in systemic sclerosis.
    Johnson SR; Laxer RM
    J Rheumatol; 2006 May; 33(5):840-1. PubMed ID: 16652415
    [No Abstract]   [Full Text] [Related]  

  • 19. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula.
    Roberts H; Curnow PA
    Australas J Dermatol; 2007 Feb; 48(1):37-9. PubMed ID: 17222301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends].
    Zelli GP; Cannata P
    Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 71.